Puerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway
Microbiology Spectrum · 02.09.2025 · 13 (9)
DOI: 10.1128/spectrum.02859-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.09.2025. Verfasst von Yang Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Isoflavones, Mastitis, Sirtuin 1, Staphylococcal Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mastitis, one of the most prevalent diseases in humans and animals, is commonly caused by local infection of the mammary gland. Puerarin inhibits mitochondrial oxidative stress and acute liver injury in mice. However, the therapeutic effect of puerarin on Staphylococcus aureus -induced mastitis is still not well understood. This study was designed to investigate the therapeutic role and mechanism of puerarin on S. aureus -induced mastitis. S. aureus was injected through the mammary gland to induce mouse mastitis. Puerarin was administered to mastitis mice via intraperitoneal injection. The iron concentration was measured using an iron assay. TNF-α and IL-1β levels in the mammary gland tissues were assessed using the ELISA kits. The signaling pathways were detected by western blot analysis. Hematoxylin and eosin staining revealed that puerarin reversed pathological injury to mammary gland tissue induced by S. aureus . Puerarin also inhibited TNF-α and IL-1β production induced by S. aureus . The significant increases in iron concentration, myeloperoxidase activity, and the malondialdehyde (MDA) level in the mammary gland tissue were attenuated by puerarin. Moreover, puerarin treatment significantly reversed the decreases in the relative glutathione (GSH) and GPX4 expression. In addition, puerarin increased the expression of SIRT1 and solute carrier family 7 member 11 (SLC7A11) and decreased p53 expression. In vitro , the inhibitory effects of puerarin on S. aureus -induced inflammation and ferroptosis were prevented by the SIRT1 inhibitor EX-527. In conclusion, the therapeutic mechanism of puerarin involves the activation of the SIRT1/p53/SLC7A11 pathway to inhibit ferroptosis and the inflammatory response. IMPORTANCE Antibiotics are the main drugs used to treat mastitis, but they can easily cause bacterial resistance and food safety issues. Therefore, finding safe and effective drugs is crucial to prevent and treat mastitis. Puerarin is the main isoflavonoid active ingredient in Pueraria lobata and has a wide range of pharmacological effects. We found that it could attenuate mastitis induced by Staphylococcus aureus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
ORCID-Profile: Yang Yang, Changlong Song, Di Zhou
Zitieren
APA
Yang, Y., Sun, L., Song, C., & Zhou, D. (2025). Puerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway. Microbiology Spectrum, 13(9). https://doi.org/10.1128/spectrum.02859-24
Vancouver
Yang Y, Sun L, Song C, Zhou D. Puerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway. Microbiology Spectrum. 2025;13(9). doi:10.1128/spectrum.02859-24
BibTeX
@article{Yang2025,
author = {Yang, Yang and Sun, Liang and Song, Changlong and Zhou, Di},
title = {Puerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway},
journal = {Microbiology Spectrum},
year = {2025},
volume = {13},
number = {9},
doi = {10.1128/spectrum.02859-24}
}
EUVIMED